Clinical trial

Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease

NCT00752232

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention ACC-001 Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention QS-21 Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention ACC-001 Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention QS-21 Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention PBS Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-12-01

PhasePHASE2

Conditions

Alzheimer Diseaseverified · MONDO: Alzheimer disease

Interventions

ACC-001BIOLOGICAL

QS-21OTHER

ACC-001BIOLOGICAL

QS-21OTHER

PBSOTHER

Sponsors & collaborators

Pfizerlead sponsor

JANSSEN Alzheimer Immunotherapy Research & Development, LLCcollaborator

Mapped research locations

TokyoJapan3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00752232 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.